Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,218 | 71,679 | 101,822 | 93,119 | 113,457 |
| Marketable Securities | 127,156 | 119,542 | 60,492 | 56,812 | 56,940 |
| Receivables | 119,075 | 110,205 | 93,592 | 92,016 | 81,343 |
| Inventories | 98,988 | 92,489 | 84,942 | 76,400 | 76,652 |
| Other current assets | 0 | 0 | 1,786 | 1,822 | 1,889 |
| TOTAL | $403,210 | $395,619 | $344,634 | $322,173 | $332,900 |
| Non-Current Assets | |||||
| PPE Net | 22,265 | 22,633 | 35,574 | 32,431 | 31,280 |
| Investments And Advances | 141,903 | 158,016 | 149,739 | 148,610 | 155,391 |
| Intangibles | 416,315 | 421,054 | 454,300 | 444,933 | 424,229 |
| Other Non-Current Assets | 61,081 | 57,514 | 51,096 | 52,987 | 51,622 |
| TOTAL | $641,564 | $659,217 | $690,709 | $678,961 | $662,522 |
| Total Assets | $1,044,774 | $1,054,836 | $1,035,343 | $1,001,134 | $995,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,293 | 17,674 | 25,148 | 24,335 | 31,140 |
| Accounts payable and accrued liabilities | 107,989 | 106,061 | 90,865 | 82,402 | 77,944 |
| Other current liabilities | 1,687 | 5,793 | 6,447 | 3,361 | 2,133 |
| TOTAL | $135,452 | $141,321 | $139,532 | $126,034 | $121,317 |
| Non-Current Liabilities | |||||
| Long Term Debt | 55,040 | 52,398 | 8,072 | 8,148 | 9,885 |
| Other Non-Current Liabilities | 24,908 | 25,845 | 24,590 | 24,537 | 19,686 |
| TOTAL | $90,453 | $87,658 | $41,295 | $45,411 | $44,526 |
| Total Liabilities | $225,905 | $228,979 | $180,827 | $171,445 | $165,843 |
| Shareholders' Equity | |||||
| Common Shares | 587,173 | 599,055 | 607,765 | 611,967 | 619,675 |
| Retained earnings | 158,978 | 161,755 | 176,909 | 175,503 | 172,920 |
| Other shareholders' equity | 48,271 | 41,383 | 46,646 | 19,283 | 14,823 |
| TOTAL | $818,869 | $825,857 | $854,516 | $829,689 | $829,579 |
| Total Liabilities And Equity | $1,044,774 | $1,054,836 | $1,035,343 | $1,001,134 | $995,422 |